This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
This free eBook goes over the 10 slides every startup pitch deck has to include, based on what we learned from analyzing 500+ pitch decks, including those from Airbnb, Uber and Spotify.
This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains 100 VC firms, with information about the countries, cities, stages, and industries they invest in, as well as their contact details.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Basel's reputation in healthcare and technology is backed by a strong group of investors. These firms are consistently placing bets on early-stage startups changing the industry.
You'll find established names like Novartis Venture Fund, with over 70 exits, alongside newer funds like Kickfund that have quickly made dozens of investments. It's a healthy mix of experience and fresh energy for founders seeking capital.
Below is our list of the best 3 VC firms in Basel.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Kickfund invests in Swiss deep-tech startups at the pre-seed and seed stages, exclusively backing winners of the Venture Kick competition. The fund acts as a co-investor during early equity rounds to help grow the national innovation ecosystem and give Swiss startups global visibility.
As one of Europe's leading venture capital firms, BioMedPartners directs private equity and mezzanine financing toward early and mid-stage healthcare and human life science companies. They concentrate on ventures in pharmaceuticals, biotechnology, diagnostics, and medical technology, guiding them from initial funding rounds to later stages of expansion.
As the venture arm of global healthcare company Novartis, they invest in early-stage life sciences and biotech companies developing novel therapeutics and platforms to address unmet medical needs. This strategic fund acts as a long-term partner, providing deep scientific expertise and substantial capital to build companies from the ground up, with a portfolio that includes biotech pioneers like Alnylam.
